Abstract:Drug‐like molecules are found by either expanding the set of molecules with known properties by selecting molecules from database and performing calculations on them or exploring the drug‐like chemical space by generating them from scratch using generative models. This review article highlights modern machine learning based methods that try to efficiently enhance our sampling capability beyond conventional screening methods. Drug design involves the process of identifying and designing novel molecules that have desirable properties and bind well to a given target receptor. Typically, such molecules are identified by screening large chemical libraries for desirable physicochemical properties and binding strength with the target protein. This traditional approach, however, has severe limitations as exhaustively screening every molecule in known chemical libraries is computationally infeasible. Furthermore, currently available molecular libraries are only a minuscule part of the entire set of possible drug‐like molecular structures (drug‐like chemical space). In this review, we discuss how the former limitation is addressed by modeling virtual screening as a search space problem and how these endeavors utilize machine learning to reduce the number of required computational experiments to identify top candidates. We follow that up by discussing generative methods that attempt to approximate the entire drug‐like chemical space providing us a path to explore beyond the known drug‐like chemical space. We place special emphasis on generative models that learn the marginal distributions conditioned on specific properties or receptor structures for efficient sampling of molecules. Through this review, we aim to highlight modern machine learning based methods that try to efficiently enhance our sampling capability beyond conventional screening methods which, in turn, would benefit drug design significantly. Therefore, we also encourage further methods of development that work on such important aspects of drug design. This article is categorized under: Data Science > Chemoinformatics Data Science > Artificial Intelligence/Machine Learning Data Science > Computer Algorithms and Programming

Novel prediction methods for virtual drug screening

Deep Learning and Virtual Drug Screening

Deep Learning in Virtual Screening: Recent Applications and Developments

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

Prediction of Drug-Target Binding Affinity Based on Deep Learning Models

Traditional and Machine Learning Approaches in Structure-Based Drug Virtual Screening

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

A compact review of progress and prospects of deep learning in drug discovery

Artificial intelligence: Machine learning approach for screening large database and drug discovery

Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review.

Is It a Prime Time for AI-powered Virtual Drug Screening?

Deep Learning Based Drug Metabolites Prediction

Artificial intelligence in drug discovery: recent advances and future perspectives

A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation

Virtual Screening of Molecules via Neural Fingerprint-based Deep Learning Technique

A Systematic Literature Review of the Current Status and Future Prospects of Machine Learning Methods and Techniques Applied to Novel Drug Discovery

The rise of deep learning and transformations in bioactivity prediction power of molecular modeling tools

A Novel Deep Neural Network Technique for Drug–Target Interaction

In silico drug discovery: a machine learning-driven systematic review

Efficient and enhanced sampling of drug‐like chemical space for virtual screening and molecular design using modern machine learning methods